$12.20-1.93%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →MiNK Therapeutics last closed at $12.20 (-1.93%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -5.4×. Its overall grade ranks 64 of 741 stocks in Healthcare.
About this company
MiNK Therapeutics last closed at $12.20 (-1.93%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 64/741
Valuation grade A+
Related stocks
- Bristol Myers SquibbCustomer
MiNK의 면역항암 파이프라인과 관련된 개발·협업 파트너로 알려짐
- Regeneron PharmaceuticalsCustomer
MiNK의 iNKT 세포치료 기술과 관련한 공동개발/협업 가능성이 있는 주요 제약 파트너
- AstraZenecaCustomer
항암면역치료 분야에서 MiNK와 같은 세포치료 기술의 잠재적 제휴·협업 대상
About MiNK Therapeutics
- What technical signals does MiNK Therapeutics (INKT) have?
- MiNK Therapeutics current technical signals: no active technical signal.
- Is MiNK Therapeutics a cup-and-handle pattern?
- No. MiNK Therapeutics has no valid Cup signal right now.
- What published figures are available for MiNK Therapeutics?
- Market cap: $57.27M. Trailing 12 months PER: -5.4×. Latest quarter PBR: -4.37×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about MiNK Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy